Top
Begin typing your search above and press return to search.
exit_to_app
Why this silence when freedoms are taken away
access_time 2021-02-24T15:29:20+05:30
access_time 2021-03-01T15:37:17+05:30
Towards a digital emergency?
access_time 2021-02-27T14:50:41+05:30
Is privatisation really good for India?
access_time 2021-02-26T15:06:44+05:30
A salutary judgement for democracy
access_time 2021-02-25T11:37:19+05:30
The slaughter of democracy in Puducherry
access_time 2021-02-24T11:27:21+05:30
DEEP READ
Towards a digital emergency?
access_time 2021-02-27T14:50:41+05:30
The slaughter of democracy in Puducherry
access_time 2021-02-24T11:27:21+05:30
Populist Fascism
access_time 2021-01-31T17:19:29+05:30
Media Freedom
access_time 2021-01-31T15:47:07+05:30
Sharjeel Imam
access_time 2021-01-30T15:19:40+05:30
exit_to_app
Homechevron_rightIndiachevron_rightCOVAXIN to be ready by ...

COVAXIN to be ready by February

text_fields
bookmark_border
COVAXIN to be ready by February
cancel

New Delhi: The indigenous vaccine named COVAXIN developed by Bharat Biotech in partnership with Indian Council of Medical Research (ICMR) is to be launched in February, reported Reuters. The vaccine which has been found to be safe in its Phase 1 and 2 is currently in phase 3 human trials.

A senior scientist informed the news agency that the vaccine has shown good efficacy and is expected to be made available by February. However, the vaccine innovator Bharat Biotech has not yet responded to this news.

The SARS-CoV-2 strain isolated by National Institute of Virology, Pune from the novel Coronavirus is used to study and manufacture the vaccine by Bharat biotech, Hyderabad.

After assessing the data of Phase 1 and 2, Drug Controller General of India (DCGI) had approved the vaccine for phase three clinical trials. Around 28,500 people including medical staffs have enrolled for phase 3 clinical trials.

Show Full Article
TAGS:COVAXIN COVID19 Health Updates 
Next Story